Hudson Bay Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-175,000
Closed -$14.7M 1422
2025
Q3
$14.7M Buy
175,000
+166,300
+1,911% +$13.7M 0.05% 277
2025
Q2
$689K Buy
+8,700
New +$692K ﹤0.01% 1028
2025
Q1
Sell
-58,000
Closed -$5.77M 1416
2024
Q4
$5.77M Sell
58,000
-192,000
-77% -$19.8M 0.02% 475
2024
Q3
$28.4M Buy
+250,000
New +$29.7M 0.11% 131
2019
Q2
Sell
-10,480
Closed -$832K 618
2019
Q1
$832K Sell
10,480
-1,037,520
-99% -$77.6M 0.01% 576
2018
Q4
$76.4M Buy
+1,048,000
New +$74M 1.02% 14
2017
Q2
Sell
-15,720
Closed -$953K 694
2017
Q1
$953K Buy
+15,720
New +$954K 0.01% 625

Other funds holding MRK

Hudson Bay Capital Management's MRK Position: Q1 2026 in Review

Hudson Bay Capital Management increased its Merck (MRK) stake by 5,539% in Q1 2026, buying an estimated $11.5M and bringing the position to 101,505 shares worth $12.2M. The position accounts for 0.04% of the portfolio, ranked #276.

Hudson Bay Capital Management first reported a position in MRK in Q4 2017 and has held it in 18 quarters since. The position peaked at $115M in Q2 2023. 3,788 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Hudson Bay Capital Management held 101,505 shares of Merck worth $12.2M as of Q1 2026.
  • Hudson Bay Capital Management bought 99,705 Merck shares in Q1 2026, an estimated $11.5M.
  • Merck made up 0.04% of Hudson Bay Capital Management's portfolio in Q1 2026, its #276 holding.
  • Hudson Bay Capital Management first reported a position in Merck in Q4 2017 and has held it in 18 quarters since.
  • Hudson Bay Capital Management's Merck position peaked at $115M in Q2 2023.
  • 3,788 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.